Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer | Cancer Pain, Intractable Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Phase 1 | 2026-08-31 | NCT00804154 | |
| Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, cancer, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, sarcoma | Not yet recruiting | Phase 1 | 2023-04-12 | NCT05361954 | |
| Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy | Long-term Follow-up | Enrolling by invitation | Not stated | 2023-01-23 | NCT05472649 |